Trials / Sponsors / Shenzhen Hemogen
Shenzhen Hemogen
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. Β-thalassemia | Phase 1 | 2024-06-12 |
| Recruiting | the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia α-thalassemia | EARLY_Phase 1 | 2022-10-08 |
| Recruiting | the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia β-thalassemia | EARLY_Phase 1 | 2022-05-27 |
| Recruiting | Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major β-thalassemia | EARLY_Phase 1 | 2020-12-01 |